BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33399316)

  • 1. High-sensitivity cardiac troponin T and the risk of heart failure in postmenopausal women of the ARIC Study.
    Ebong IA; Wilson MD; Bertoni AG; Appiah D; Polonsky T; Michos ED; Ballantyne C; Chang P
    Menopause; 2021 Jan; 28(3):284-291. PubMed ID: 33399316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
    Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
    Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-pro B-type natriuretic peptide, early menopause, and incident heart failure in postmenopausal women of the ARIC study.
    Ebong IA; Wilson MD; Chang P; Appiah D; Polonsky T; Ballantyne C; Bertoni AG
    Menopause; 2022 Jan; 29(3):309-316. PubMed ID: 35213518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Cardiovascular Disease and Fall Risk in Older Adults: Results From the Atherosclerosis Risk in Communities Study.
    Juraschek SP; Daya N; Appel LJ; Miller ER; Matsushita K; Michos ED; Windham BG; Ballantyne CM; Selvin E
    J Am Geriatr Soc; 2019 Sep; 67(9):1795-1802. PubMed ID: 31493355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 25-Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study.
    Michos ED; Selvin E; Misialek JR; McEvoy JW; Ndumele CE; Folsom AR; Ballantyne CM; Lutsey PL
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27821403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
    Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
    Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study.
    Nambi V; Liu X; Chambless LE; de Lemos JA; Virani SS; Agarwal S; Boerwinkle E; Hoogeveen RC; Aguilar D; Astor BC; Srinivas PR; Deswal A; Mosley TH; Coresh J; Folsom AR; Heiss G; Ballantyne CM
    Clin Chem; 2013 Dec; 59(12):1802-10. PubMed ID: 24036936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
    Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
    Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Sensitivity Cardiac Troponin, Natriuretic Peptide, and Long-Term Risk of Acute Kidney Injury: The Atherosclerosis Risk in Communities (ARIC) Study.
    Ishigami J; Kim Y; Sang Y; Menez SP; Grams ME; Skali H; Shah AM; Hoogeveen RC; Selvin E; Solomon SD; Ballantyne CM; Coresh J; Matsushita K
    Clin Chem; 2021 Jan; 67(1):298-307. PubMed ID: 33418586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
    Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
    Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
    Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
    JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-Year Change in High-Sensitivity Cardiac Troponin T and Risk of Subsequent Coronary Heart Disease, Heart Failure, and Death.
    McEvoy JW; Chen Y; Ndumele CE; Solomon SD; Nambi V; Ballantyne CM; Blumenthal RS; Coresh J; Selvin E
    JAMA Cardiol; 2016 Aug; 1(5):519-28. PubMed ID: 27439107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study.
    Pokharel Y; Sun W; Virani SS; Nambi V; Hoogeveen RC; Chang PP; Ndumele CE; Solomon SD; Bozkurt B; Selvin E; Ballantyne CM; Deswal A
    JACC Heart Fail; 2017 Jan; 5(1):56-63. PubMed ID: 28017350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined use of the novel biomarkers high-sensitivity troponin T and ST2 for heart failure risk stratification vs conventional assessment.
    Lupón J; de Antonio M; Galán A; Vila J; Zamora E; Urrutia A; Bayes-Genis A
    Mayo Clin Proc; 2013 Mar; 88(3):234-43. PubMed ID: 23384388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Circulating Troponin Concentrations, Left Ventricular Systolic and Diastolic Functions, and Incident Heart Failure in Older Adults.
    Myhre PL; Claggett B; Ballantyne CM; Selvin E; Røsjø H; Omland T; Solomon SD; Skali H; Shah AM
    JAMA Cardiol; 2019 Oct; 4(10):997-1006. PubMed ID: 31483438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity, subclinical myocardial injury, and incident heart failure.
    Ndumele CE; Coresh J; Lazo M; Hoogeveen RC; Blumenthal RS; Folsom AR; Selvin E; Ballantyne CM; Nambi V
    JACC Heart Fail; 2014 Dec; 2(6):600-7. PubMed ID: 25443112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.
    Saunders JT; Nambi V; de Lemos JA; Chambless LE; Virani SS; Boerwinkle E; Hoogeveen RC; Liu X; Astor BC; Mosley TH; Folsom AR; Heiss G; Coresh J; Ballantyne CM
    Circulation; 2011 Apr; 123(13):1367-76. PubMed ID: 21422391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.